Loading
Latest filing published 27 Feb 2025 for Tonix Pharmaceuticals Holding Corp., €0.
Based on 6 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
All filings by Gregory M. Sullivan on record concern Tonix Pharmaceuticals Holding Corp. The record holds 10 filings, for trades running from 11 June 2015 to 5 February 2025.
On the market, this insider has only ever bought: 8 purchases, €226k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 1 share grant.
The median purchase comes to €25k. Of 3 purchases, 3 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. Ninety days after publication, 6 purchases show a median change of -22.6%, with the price up in 33% of them. These figures describe past trades and do not predict future prices.
The latest filing, published on 27 February 2025, reports a transaction of €0 in Tonix Pharmaceuticals Holding Corp. The last purchase on record was published on 19 August 2020, which is 2,258 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations